| human | Q5 |
| P8446 | Gateway to Research person ID | 33FEFC5F-4CFC-437C-883E-53B2091F401F |
| P496 | ORCID iD | 0000-0003-4627-3496 |
| P1153 | Scopus author ID | 6701449684 |
| P69 | educated at | University of Birmingham | Q223429 |
| P108 | employer | Birmingham and Midland Eye Centre | Q30280073 |
| University of Birmingham | Q223429 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q39716636 | "In use" expiry date for eyedrops |
| Q53163998 | "Triple-TEN" in the treatment of acute ocular complications from toxic epidermal necrolysis. |
| Q46207185 | A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjögren's Syndrome. |
| Q91760450 | A self-healing hydrogel eye drop for the sustained delivery of decorin to prevent corneal scarring |
| Q92682385 | Adherence to Topical Medication in Patients with Inflammatory Eye Disease |
| Q42560166 | Aqueous humor suppression of dendritic cell function helps maintain immune regulation in the eye during human uveitis |
| Q35593086 | Blepharokeratoconjunctivitis in children: diagnosis and treatment |
| Q32114933 | Capsulorhexis phymosis following uncomplicated phacoemulsification surgery. |
| Q42913236 | Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation? |
| Q61628177 | Chapter-12 Sj�gren�s syndrome and other causes of cicatrizing conjunctivitis |
| Q41380558 | Characterisation of 11beta-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat. |
| Q60207412 | Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye |
| Q44653346 | Characterization of human trophoblast as a mineralocorticoid target tissue |
| Q39020279 | Characterization of vitamin D production by human ocular barrier cells |
| Q61628182 | Chemical and Topographical Effects on Cell Differentiation and Matrix Elasticity in a Corneal Stromal Layer Model |
| Q61628179 | Childhood blepharokeratoconjunctivitis: characterising a severe phenotype in white adolescents |
| Q50016166 | Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry |
| Q61628188 | Concurrent Oral 10 - Connective Tissue Disease [OP65-OP72]: OP65. Molecular and Cellular Evolution of Functional Tertiary Lymphoid Structures in Salivary Glands of NOD Mice |
| Q37354234 | Conjunctival Neutrophils Predict Progressive Scarring in Ocular Mucous Membrane Pemphigoid |
| Q37767562 | Contact lens-related microbial keratitis in deployed British military personnel. |
| Q48111125 | Corticosteroids, 11beta-hydroxysteroid dehydrogenase isozymes and the rabbit choroid plexus. |
| Q35149219 | Cortisol biosynthesis in the human ocular surface innate immune response. |
| Q34789732 | Cytokine production and antigen recognition by human mucosal homing conjunctival effector memory CD8+ T cells |
| Q38817004 | Defining Ocular Surface Disease Activity and Damage Indices by an International Delphi Consultation |
| Q37709776 | Defining the limits of normal conjunctival fornix anatomy in a healthy South Asian population |
| Q93005173 | Disease activity and patient reported outcome measures in Sjögren's - what are the best tools to evaluate? |
| Q61628159 | Dry Eye Disease: Time to Introduce Ocular Surface Stress Tests? |
| Q48939220 | Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? |
| Q37012774 | Elevation of conjunctival epithelial CD45INTCD11b⁺CD16⁺CD14⁻ neutrophils in ocular Stevens-Johnson syndrome and toxic epidermal necrolysis. |
| Q40383414 | Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry |
| Q51793663 | Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry. |
| Q60207342 | Endogenous Cortisol and TGF- in Human Aqueous Humor Contribute to Ocular Immune Privilege by Regulating Dendritic Cell Function |
| Q48847556 | Estimating indirect costs in primary Sjögren's syndrome |
| Q61628194 | Evaluation of Mucous Membrane Pemphigoid with Ocular Involvement in Young Patients |
| Q35215156 | Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom |
| Q33180368 | Evaluation of foldable intraocular lenses in patients with uveitis. |
| Q112727034 | Evaluation of full-length nanopore 16S sequencing for detection of pathogens in microbial keratitis |
| Q37233835 | Exploring the pathogenesis of IIH: an inflammatory perspective |
| Q42443601 | Expression and distribution of the serum and glucocorticoid regulated kinase and the epithelial sodium channel subunits in the human cornea |
| Q54365191 | Gene expression and miR profiles of human corneal fibroblasts in response to dexamethasone. |
| Q60207415 | Hand hygiene practices among ophthalmologists |
| Q59305616 | Immunosuppressive Therapy for Ocular Mucous Membrane Pemphigoid |
| Q36238300 | Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom |
| Q42993948 | Infectious crystalline keratopathy treated with intrastromal antibiotics |
| Q51674384 | Influence of cell and collagen concentration on the cell-matrix mechanical relationship in a corneal stroma wound healing model. |
| Q54440671 | Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling. |
| Q61628203 | Letter |
| Q61628206 | Letter |
| Q61628162 | List of Contributors |
| Q35105041 | Long-term biocompatibility and visual outcomes of a hydrophilic acrylic intraocular lens in patients with uveitis |
| Q28750454 | Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study |
| Q61628200 | Monocanalicular nasolacrimal duct intubation11The following letters address an article that appeared in the February 1998 issue of the Journal: Monocanalicular intubation with Monoka tubes for the treatment of congenital nasolacrimal duct obstruction |
| Q51330423 | Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. |
| Q57803321 | NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases - a diagnostic tool? |
| Q41697485 | Neuron J is a rapid and reliable open source tool for evaluating corneal nerve density in herpes simplex keratitis |
| Q61628161 | Neurotrophic keratopathy |
| Q61628169 | Ocular features |
| Q61628187 | Online Monitoring of the Mechanical Behavior of Collagen Hydrogels: Influence of Corneal Fibroblasts on Elastic Modulus |
| Q61628185 | Online Monitoring the Mechanical Remodeling of Hydrogels by Corneal Fibroblasts |
| Q51874482 | Patient-reported outcomes in primary Sjogren's syndrome: comparison of the long and short versions of the Profile of Fatigue and Discomfort--Sicca Symptoms Inventory. |
| Q40232504 | Periodontitis prevalence and serum antibody reactivity to periodontal bacteria in primary Sjögren's syndrome: a pilot study |
| Q57897058 | Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis |
| Q57897062 | Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis |
| Q42220318 | Post-phacoemulsification cytomegalovirus corneal endotheliitis diagnosis and management |
| Q61628181 | Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension |
| Q51893824 | Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. |
| Q42585992 | Rheumatoid corneal melt: autoimmunity or infection? |
| Q37456478 | Serum eye drops, amniotic membrane and limbal epithelial stem cells--tools in the treatment of ocular surface disease |
| Q40661471 | Serum- and glucocorticoid-regulated kinase isoform-1 and epithelial sodium channel subunits in human ocular ciliary epithelium |
| Q61628193 | Sjogren's Systemic Clinical Activity Index (SCAI) a systemic disease activity measure for use in clinical trials in primary Sjogren's syndrome |
| Q61628174 | Sjögren’s syndrome—clinical features |
| Q53478296 | Soluble gp130, an antagonist of IL-6 transsignaling, is elevated in uveitis aqueous humor. |
| Q60300381 | Sustained release of decorin to the surface of the eye enables scarless corneal regeneration |
| Q61628168 | THU0259 Respiratory symptoms in primary sjÖgren's syndrome, a cross-sectional study of the oasis cohort |
| Q46670025 | Ten-year experience of pulsed intravenous cyclophosphamide and methylprednisolone protocol (PICM protocol) in severe ocular inflammatory disease |
| Q53786763 | The British Society for Rheumatology guideline for the management of adults with primary Sjögren's Syndrome. |
| Q55970269 | The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome |
| Q61628165 | The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome |
| Q49925673 | The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summary |
| Q49925651 | The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report |
| Q61628191 | The Sjogren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjogren's syndrome |
| Q37607603 | The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome |
| Q113100825 | The conjunctival extracellular matrix, related disorders and development of substrates for conjunctival restoration |
| Q36483107 | The dominant human conjunctival epithelial CD8αβ+ T cell population is maintained with age but the number of CD4+ T cells increases |
| Q39037778 | The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis |
| Q104491166 | The management of Sjögren's syndrome: British Society for Rheumatology guideline scope |
| Q43251082 | The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy |
| Q51415210 | The role of preoperative subconjunctival mydricaine and topical diclofenac sodium 0.1% in maintaining mydriasis during vitrectomy. |
| Q90111824 | Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity |
| Q61628196 | Ultrastructural examination of two cases of stromal microsporidial keratitis |
| Q91146042 | Validation of a clinical assessment tool for cicatrising conjunctivitis |
| Q34996874 | Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis |
| Q61628204 | Variation in astigmatism following the single-step, self-sealing clear corneal section for phacoemulsification |
Search more.